Major stroke recovery trial seeks to reduce Long-Term disability
Disease control
Recruiting now
This large, late-stage study is testing whether a new intravenous medicine called SHPL-49 can help people recover better after an acute ischemic stroke. About 1,100 participants who have recently had a stroke will receive either the study medicine or a placebo infusion for 7 days…
Phase: PHASE3 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC